Lord, Abbett & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $362M | Buy |
1,482,192
+152,507
| +11% | +$35.5M | 1.18% | 10 |
|
|
2025
Q4 | $275M | Buy |
1,329,685
+191,239
| +17% | +$37.8M | 0.84% | 24 |
|
|
2025
Q3 | $211M | Buy |
1,138,446
+569,700
| +100% | +$97.6M | 0.63% | 38 |
|
|
2025
Q2 | $86.9M | Sell |
568,746
-137,353
| -19% | -$21.1M | 0.28% | 98 |
|
|
2025
Q1 | $117M | Buy |
706,099
+274,905
| +64% | +$43M | 0.42% | 66 |
|
|
2024
Q4 | $62.4M | Buy |
431,194
+128
| +0% | +$19.8K | 0.2% | 137 |
|
|
2024
Q3 | $69.9M | Buy |
+431,066
| New | +$68.7M | 0.22% | 135 |
|
|
2021
Q2 | – | Sell |
-105,242
| Closed | -$17.3M | – | 670 |
|
|
2021
Q1 | $17.3M | Sell |
105,242
-699,156
| -87% | -$113M | 0.04% | 432 |
|
|
2020
Q4 | $127M | Sell |
804,398
-343,886
| -30% | -$50.7M | 0.33% | 87 |
|
|
2020
Q3 | $171M | Sell |
1,148,284
-301,697
| -21% | -$44.6M | 0.55% | 35 |
|
|
2020
Q2 | $204M | Buy |
1,449,981
+241,850
| +20% | +$35.2M | 0.71% | 10 |
|
|
2020
Q1 | $158M | Buy |
1,208,131
+23,219
| +2% | +$3.29M | 0.7% | 15 |
|
|
2019
Q4 | $173M | Sell |
1,184,912
-27,419
| -2% | -$3.72M | 0.58% | 21 |
|
|
2019
Q3 | $157M | Sell |
1,212,331
-287,702
| -19% | -$37.9M | 0.53% | 26 |
|
|
2019
Q2 | $209M | Sell |
1,500,033
-671,540
| -31% | -$93M | 0.68% | 10 |
|
|
2019
Q1 | $304M | Buy |
2,171,573
+121,137
| +6% | +$16.2M | 1.01% | 3 |
|
|
2018
Q4 | $265M | Sell |
2,050,436
-163,147
| -7% | -$22.8M | 0.97% | 7 |
|
|
2018
Q3 | $306M | Buy |
2,213,583
+149,748
| +7% | +$19.9M | 0.85% | 6 |
|
|
2018
Q2 | $250M | Sell |
2,063,835
-464,515
| -18% | -$58M | 0.73% | 9 |
|
|
2018
Q1 | $324M | Buy |
2,528,350
+246,437
| +11% | +$33.3M | 0.96% | 4 |
|
|
2017
Q4 | $319M | Buy |
2,281,913
+39,110
| +2% | +$5.45M | 0.91% | 4 |
|
|
2017
Q3 | $292M | Sell |
2,242,803
-253,597
| -10% | -$33.6M | 0.85% | 5 |
|
|
2017
Q2 | $330M | Sell |
2,496,400
-148,544
| -6% | -$18.9M | 0.98% | 4 |
|
|
2017
Q1 | $329M | Sell |
2,644,944
-56,856
| -2% | -$6.79M | 0.99% | 5 |
|
|
2016
Q4 | $311M | Sell |
2,701,800
-286,251
| -10% | -$33.1M | 0.95% | 6 |
|
|
2016
Q3 | $353M | Sell |
2,988,051
-663,887
| -18% | -$80.5M | 1.08% | 4 |
|
|
2016
Q2 | $443M | Buy |
3,651,938
+489,286
| +15% | +$55.6M | 1.39% | 2 |
|
|
2016
Q1 | $342M | Buy |
3,162,652
+1,429,110
| +82% | +$148M | 1.08% | 5 |
|
|
2015
Q4 | $178M | Sell |
1,733,542
-892,840
| -34% | -$89.8M | 0.54% | 23 |
|
|
2015
Q3 | $245M | Buy |
2,626,382
+753,779
| +40% | +$72.9M | 0.74% | 8 |
|
|
2015
Q2 | $183M | Sell |
1,872,603
-214,500
| -10% | -$21.5M | 0.48% | 26 |
|
|
2015
Q1 | $210M | Buy |
2,087,103
+691,853
| +50% | +$70.4M | 0.53% | 23 |
|
|
2014
Q4 | $146M | Buy |
1,395,250
+383,031
| +38% | +$40.4M | 0.37% | 63 |
|
|
2014
Q3 | $108M | Sell |
1,012,219
-385,496
| -28% | -$40M | 0.27% | 90 |
|
|
2014
Q2 | $146M | Buy |
1,397,715
+643,783
| +85% | +$65.1M | 0.33% | 76 |
|
|
2014
Q1 | $74.1M | Sell |
753,932
-119,511
| -14% | -$11.1M | 0.17% | 169 |
|
|
2013
Q4 | $80M | Sell |
873,443
-298,221
| -25% | -$27.5M | 0.18% | 161 |
|
|
2013
Q3 | $101M | Sell |
1,171,664
-727,262
| -38% | -$65.2M | 0.23% | 122 |
|
|
2013
Q2 | $163M | Buy |
+1,898,926
| New | +$161M | 0.38% | 54 |
|
Other funds holding JNJ
VCM
VPM
Lord, Abbett & Co's JNJ Position: Q1 2026 in Review
Lord, Abbett & Co increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $35.5M and bringing the position to 1,482,192 shares worth $362M. The position accounts for 1.18% of the portfolio, ranked #10.
Lord, Abbett & Co first reported a position in JNJ in Q2 2013 and has held it in 39 quarters since. The position peaked at $443M in Q2 2016. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Lord, Abbett & Co held 1,482,192 shares of Johnson & Johnson worth $362M as of Q1 2026.
- Lord, Abbett & Co bought 152,507 Johnson & Johnson shares in Q1 2026, an estimated $35.5M.
- Johnson & Johnson made up 1.18% of Lord, Abbett & Co's portfolio in Q1 2026, its #10 holding.
- Lord, Abbett & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 39 quarters since.
- Lord, Abbett & Co's Johnson & Johnson position peaked at $443M in Q2 2016.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.